Aetion

News

May 5, 2022

Press Release

EY Announces Carolyn Magill and Dr. Jeremy Rassen of Aetion as Entrepreneur Of The Year® 2022 New York Award Finalists
April 21, 2022

Press Release

National Evaluation System for health Technology Coordinating Center (NESTcc) Partners with Aetion to Transform the Role of RWE for Medical Devices
March 8, 2022

Press Release

Cognito Therapeutics and Aetion announce partnership to use artificial intelligence to identify rapidly progressing forms of mild cognitive impairment and Alzheimer’s disease
February 7, 2022

Using real-world evidence to advance COVID-19 medical countermeasures

FDA
January 4, 2022

Aetion acquires Replica Analytics to bring aboard synthetic data capabilities

MedCity News
January 4, 2022

Aetion acquires synthetic data platform Replica Analytics

HIT Consultant
January 4, 2022

Aetion snaps up AI health data specialist Replica Analytics

Fierce Biotech
January 4, 2022

Real-world evidence firm Aetion grabs privacy-protected synthetic data provider Replica Analytics

Fierce Healthcare
January 4, 2022

Aetion snaps up synthetic real-world data company Replica Analytics

MobiHealthNews
January 4, 2022

Press Release

Aetion acquires synthetic data trailblazer Replica Analytics
December 1, 2021

Press Release

European Medicines Agency selects Aetion to support safety and efficacy research in Europe
October 26, 2021

FDA, Aetion expand RWE work to focus on inpatient COVID-19 therapies

InsideHealthPolicy
October 21, 2021

Real-world evidence: ‘Labor-intensive’ data standardization may be required by US FDA

Pink Sheet
October 21, 2021

How to collect and submit RWD to win approval for a new drug indication: FDA spells it out in a long-awaited guidance

Endpoints
October 21, 2021

FDA contracts Aetion’s real-world evidence platform to assess COVID-19 treatments

Fierce Healthcare
October 21, 2021

Press Release

FDA selects Aetion Evidence Platform® to advance regulatory science and innovation
October 17, 2021

Heard at HLTH: Can we get Ironman’s J.A.R.V.I.S. in the world of drug development?

MedCity News
October 15, 2021

FDA adcomm votes unanimously in support of a J&J Covid-19 booster two months after one-dose shot

Endpoints News
October 7, 2021

England’s NICE starts work to develop RWE standards

Pink Sheet
October 6, 2021

Aetion to collaborate with UK’s NICE on RWE

Endpoints News

The Evidence Digest

Subscribe to our newsletter for insights and updates on research and applications for real-world evidence.

arrowcalendarchevronclosecollapsecountdownfacebookflickrinstagramlinelinkedinlocationpinsearchsocialtwitteryoutube